Kazuki Iio

Kazuki Iio

Auto-generated profile, based on publicly available information

Kazuki Iio

Division of Pediatric Emergency Medicine, Department of Pediatric Emergency and Critical Care Medicine Tokyo Metropolitan Children's Medical Center Tokyo Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in The Journal of Pediatrics
Verified
Journal Article
Closed access
KIKazuki Iio
Kazuki Iio
YMYoshihiko Morikawa
Yoshihiko Morikawa
KMKoichi Miyata
Koichi Miyata
TKTetsuji Kaneko
Tetsuji Kaneko
MMMasahiro Misawa
Masahiro Misawa
MMMasaru Miura
Masaru Miura

16 August 2020 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
KIKazuki Iio
Kazuki Iio
KUKazuhiro Uda
Kazuhiro Uda
HHHiroshi Hataya
Hiroshi Hataya
FYFumihiko Yasui
Fumihiko Yasui
THTomoko Honda
Tomoko Honda
MMMasaru Miura
Masaru Miura

16 August 2022 in Pediatrics International
Verified
Journal Article
Closed access
KIKazuki Iio
Kazuki Iio
YHYusuke Hagiwara
Yusuke Hagiwara
OSOsamu Saito
Osamu Saito
YIYu Ishida
Yu Ishida
YHYuho Horikoshi
Yuho Horikoshi

1 June 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
KIKazuki Iio
Kazuki Iio
ONOsamu Nomura
Osamu Nomura
AKAkiko Kinumaki
Akiko Kinumaki
YAYujiro Aoki
Yujiro Aoki
HSHiroyuki Satoh
Hiroyuki Satoh
HHHiroshi Hataya
Hiroshi Hataya

24 March 2023 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
KIKazuki Iio
Kazuki Iio
YMYoshihiko Morikawa
Yoshihiko Morikawa
KMKoichi Miyata
Koichi Miyata
TKTetsuji Kaneko
Tetsuji Kaneko
MMMasahiro Misawa
Masahiro Misawa
MMMasaru Miura
Masaru Miura
Introduction: Kawasaki disease (KD) patients with a high risk of coronary artery aneurysm (CAA) development are well characterized and targeted for intensified primary intravenous immunoglobulin (IVIG) treatment. However, the characteristics of KD patients with a low CAA risk are less well-known. Methods: The present study was a secondary analysis of Prospective Observational study on STRAtified treatment with Immunoglobulin plus Steroid Efficacy for Kawasaki disease (Post RAISE), a multicenter, prospective cohort study of KD patients in Japan. The target of the analysis was patients with a Kobayashi score 2.5, age <12 months at fever onset, nonresponsiveness to IVIG, low neutrophils, high platelets and high C-reactive protein were independent predictors of CAA during the acute phase. The decision tree created by using these risk factors identified 679 KD patients who had a low incidence of CAA during the acute phase (4.1%) and no medium or large CAA. Conclusions: The present study identified a KD subpopulation with a low CAA risk comprising around a quarter of the entire Post RAISE cohort.

15 February 2019 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
KIKazuki Iio
Kazuki Iio
KSKeiko Soneda
Keiko Soneda
ASAkihiro Shimotakahara
Akihiro Shimotakahara
HHHiroshi Hataya
Hiroshi Hataya
TKTatsuo Kono
Tatsuo Kono